Population Pharmacokinetics of Caspofungin and Dosing Optimization in Children With Allogeneic Hematopoietic Stem Cell Transplantation

Caspofungin is the first echinocandin antifungal agent that licented for pediatric use in invasive candidiasis and aspergillosis. In this study, we evaluated the population pharmacokinetics of caspofungin and investigate appropriate dosing optimization against Candida spp. in children with allogenei...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: Niu, Chang-He, Xu, Hua, Gao, Liu-Liu, Nie, Ying-Ming, Xing, Li-Peng, Yu, Li-Peng, Wu, San-Lan, Wang, Yang
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7061854/
https://ncbi.nlm.nih.gov/pubmed/32194415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00184
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars